Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00025292
DRKS00025292
Recruiting
Not Applicable

Investigation to detect metabolic changes in the early phase of a critical illness - MACI-E (Metabolic Alterations in Critical Illness - Early)

niversitätsmedizin Göttingen0 sites20 target enrollmentMarch 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscritical illnesses

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
critical illnesses
Sponsor
niversitätsmedizin Göttingen
Enrollment
20
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Göttingen

Eligibility Criteria

Inclusion Criteria

  • •Severely ill patients with
  • •\- Subarachnoid hemorrhage (Hunt\&Hess 4 or 5\) or
  • •\- Intracranial bleeding or
  • •\- Severe traumatic brain injury and
  • •\- all requiring mechnical ventilation

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Assessment of changes in energy metabolism in liver and skeletal muscle in patients suffering from acromegaly by magnetic resonance spectroscopyAcromegalyTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]
EUCTR2013-004782-14-ATMedizinische Universität Wien, KIMIII, Abteilung für Endokrinologie und Stoffwechsel
Recruiting
Not Applicable
Investigation of metabolic profile, body tissue loss and change of the quality of life in patients with ischaemic stroke.I63.5I63.8Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteriesOther cerebral infarction
DRKS00000514Center for Stroke Research Berlin, Charite, Universitätsmedizin Berlin, Campus Virchow-Klinikum 150
Not yet recruiting
Not Applicable
A study to assess the endogenous metabolic alterations and pharmacokinetic·pharmacodynamic characteristics after oral administrations of dapagliflozin in healthy and obese adult volunteersEndocrine, nutritional and metabolic diseases
KCT0007864Kyungpook National University Hospital30
Not yet recruiting
Not Applicable
Quantification of the enzymes responsible for metabolism in the vesicles secreted by biological cellsHealth Condition 1: E11- Type 2 diabetes mellitus
CTRI/2024/01/061346DST INSPIRE
Recruiting
Not Applicable
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)Brain Tumor Adult
NCT03067467University of Texas Southwestern Medical Center25